Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery

Abroad (travel likely)Recruiting

Conditions

Oral Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Study coordinator (Joseph Zenga, MD) · jyzenga@mcw.edu · 414-955-0889

Study leads

Joseph Zenga, MD
Principal Investigator
Medical College of Wisconsin

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Glioblastoma Multiforme (GBM) · Glioblastoma · Glioma of Brain

Abroad (travel likely)RecruitingPHASE1, PHASE2

New York, United States

Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy

Cancer · Neoplasms

Abroad (travel likely)Recruiting

Irvine, United States · Newport Beach, United States

Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain

Oral Cancer · Squamous Cell Carcinoma

Abroad (travel likely)Recruiting

New York, United States

Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients with Risk Factors

Cancer

Abroad (travel likely)Recruiting

Pierre-Bénite, France